系统性炎症和与胰岛素抵抗相关的指标预测癌症缓解症患者的结果不佳
Guo-Tian Ruan1,2,3,4, Li Deng1,2,3,4, Hai-Lun Xie1,2,3,4
1Department of Gastrointestinal Surgery/Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, 10 Tie Yi Road, Beijing, 100038, China.
Cancer & metabolism
|January 25, 2024
概括
在C反应性蛋白 (CRP) - 三甘油 - 葡萄糖 (TyG) 指数 (CTI) 有效预测癌症缓解症患者的生存率. 这种炎症和胰岛素耐药性标志物为临床实践提供了宝贵的预后工具.
科学领域:
- 生物医学研究的研究.
- 临床瘤学临床瘤学
- 代谢综合征是代谢综合征.
背景情况:
- 在C反应性蛋白 (CRP) - 三甘油 - 葡萄糖 (TyG) 指数 (CTI) 与不良的癌症预后有关.
- 癌症缓解症中CTI的预后价值仍然没有得到验证.
研究的目的:
- 调查CTI作为癌症缓解症患者的预后标记物的临床实用性.
- 为了验证CTI在这个人群中生存的预测能力.
主要方法:
- 未来的多中心队列研究,包括1411名患有癌症缓冲症的患者.
- 使用了内部 (30%) 和外部 (307名患者) 验证队列.
- 单变量,多变量生存分析,ROC和校准曲线评估了预后价值.
主要成果:
- 在总体,内部和外部队列中,CTI表现出显著的预后价值.
- 升高的CTI每增加标准偏差,死亡风险增加22-35%.
- 高CTI预测食道癌和结肠直肠癌亚组的生存时间较短.
结论:
- CTI作为一个可靠的预后工具,用于预测癌症缓解症的短期和长期生存率.
- 可以将CTI整合到临床实践中,以改善患者管理和风险分层.
更多相关视频
相关概念视频
Psychoneuroimmunology: Diabetes and Cancer
29
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
29
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
Inflammatory Bowel Disease II: Crohn's Disease
244
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
244
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K


